Trial record 1 of 1 for:    s1304
Previous Study | Return to List | Next Study

S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01903811
Recruitment Status : Active, not recruiting
First Posted : July 19, 2013
Last Update Posted : March 7, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : November 2017
  Estimated Study Completion Date : July 2019